Replies to post #374678 on Amarin Corp Plc (AMRN)

[MNBioMike]

Coverage changes are really coming thru strong in the script #s.

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Toddrobertking]

Insurance coverage changes appear to be #fakenews

[TastyTheElf]

Didn’t noeructation win with 69688?

[rafunrafun]

Scripts for week ending April 8, 2022

Drug Industry TRx: +1.6% w/w; +12.0% y/y

Vascepa
TRx 72,672; +4.3% (+2,982) w/w; -12.3% y/y
NRx 34,096; +6.7% (+2,142) w/w; -10.7% y/y
Ref 38,576; +2.2% (+840) w/w; -13.7% y/y

Lovaza (Generic & Brand)
TRx 62,610; +0.0% (+19) w/w; +2.9% y/y
NRx 32,133; -1.2% (-393) w/w; +6.7% y/y
Ref 30,474; +1.4% (+412) w/w; -0.8% y/y

Generic Vascepa
TRx 29,969; -2.2% (-668) w/w; As % of total V: 29.2%
NRx 15,855; -0.4% (-763) w/w; As % of total V: 31.7%
Ref 14,114; +0.7% (+95) w/w; As % of total V: 26.8%

Generic Vascepa by Manufacturer
Hikma - TRx 6,861; (-601) w/w; Generic share 22.9%; Total V share 6.7%
Reddy - TRx 12,867; (-644) w/w; Generic share 42.9%; Total V share 12.5%
Apotex - TRx 10,240; (+576) w/w; Generic share 34.2%; Total V share 10.0%

Vascepa + Generic Vascepa
TRx 102,640; +2.3% (+2,314) w/w; +13.7% y/y
NRx 49,951; +2.8% (+1,379) w/w; +18.4% y/y
Ref 52,689; +1.8% (+934) w/w; +9.7% y/y